title: Haloperidol versus chlorpromazine for treatment of schizophrenia.
authors.affiliation: claudialeucht@gmx.de
authors.forename: C
authors.initials: C
authors.lastname: Leucht
authors.forename: M
authors.initials: M
authors.lastname: Kitzmantel
authors.forename: L
authors.initials: L
authors.lastname: Chua
authors.forename: J
authors.initials: J
authors.lastname: Kane
authors.forename: S
authors.initials: S
authors.lastname: Leucht
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use*; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D006220:Haloperidol; D002746:Chlorpromazine